Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,600 signal articles · 321 in last 24h · 112,439 total before filter · latest 27m ago

321last 24h

2139last 7d

381● bullish (7d)

186● bearish (7d)

204publishers

All Macro299 Earnings1210 M&A91 Regulatory22 Product13 Analyst20

✕ clear all filtersticker: GENBsentiment: bullishSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Insider Monkey115d agobullish

H.C. Wainwright Initiates Coverage of Generate Biomedicines (GENB) With a Buy Rating

Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the best low priced biotech stocks to invest in. On April 13, H.C. Wainwright initiated coverage of Generate Biomedicines, Inc. (NASDAQ:GENB) with a Buy rating, setting a $16 price target. The firm told investors in a research note that the stock has fallen over 20% even as GB-0895 advanced into […]

GENB